Novel glucokinase mutations in patients with monogenic diabetes - clinical outline of GCK-MD and potential for founder effect in Slavic population. | Clin Genet;81(3): 278-83, 2012 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Novel glucokinase mutations in patients with monogenic diabetes - clinical outline of GCK-MD and potential for founder effect in Slavic population.

Borowiec, M; Antosik, K; Fendler, W; Deja, G; Jarosz-Chobot, P; Mysliwiec, M; Zmyslowska, A; Malecki, M; Szadkowska, A; Mlynarski, W.

Affiliation

Borowiec M; Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.

Clin Genet ; 81(3): 278-83, 2012 Mar.

Article in En | MEDLINE | ID: mdl-21348868

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Serine-Threonine Kinases / Founder Effect / Diabetes Mellitus / Mutation Limits: Female / Humans / Male Language: En Journal: Clin Genet Year: 2012 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Serine-Threonine Kinases / Founder Effect / Diabetes Mellitus / Mutation Limits: Female / Humans / Male Language: En Journal: Clin Genet Year: 2012 Document type: Article Affiliation country: Country of publication: